Big data aims to match depression patients with best meds
NCT ID NCT05267873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at nearly 10,000 patients to see if combining information from clinical trials and electronic health records can help predict which depression medication works best for each person. Researchers analyzed data from people prescribed duloxetine or vortioxetine. The goal was to improve personalized mental health care, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, MAJOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland, 21205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single dose of a new drug boost depression relief?
- Can a new pill ease depression without Add-Ons?
- Brain scans could make TMS for depression more precise
- Can brain training help depressed young adults stop ruminating?
- 45,000 students to be tracked: can we predict who will fall into depression?
- New depression pill BI 1569912 put to the test in 225-Person trial